MLC901 in Hypoxic-ischemic Brain Injury Patients; A Double-blind, Randomized Placebo-controlled Trial

NCT05621590 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Hypoxic Ischaemic Encephalopathy Due to Cardiac Arrest

Interventions

DRUG: MLC 901
DRUG: Placebo

Sponsor

Shahid Beheshti University of Medical Sciences